ViaLase

Corona Del Mar, United States

ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.

$40.0M raised

Apr 2024

Series C

Top Investors

Arboretum VenturesVersant VenturesVenture InvestorsFalcon Vision

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ViaLase raised?

ViaLase has raised $40.0M in total funding. The most recent round was Series C. The last funding was announced in April 2024.

Who are ViaLase's investors?

ViaLase's investors include Arboretum Ventures, Versant Ventures, Venture Investors, Falcon Vision.

Where is ViaLase headquartered?

ViaLase is headquartered in Corona Del Mar, United States.

What does ViaLase do?

ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.

What stage is ViaLase at?

ViaLase is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2024.

MLA

"ViaLase — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/vialase. Accessed June 17, 2026.

APA

VCBacked. (2024). ViaLase — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/vialase

Wikipedia (cite web)

{{cite web |title=ViaLase — Funding & Investors |url=https://www.vcbacked.co/company/vialase |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2024.